Literature DB >> 2886714

Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders.

R Anand, F Siegal, C Reed, T Cheung, S Forlenza, J Moore.   

Abstract

To understand the mechanism of HIV-mediated neuropathology five viral isolates were obtained from four AIDS cases with central nervous system manifestations as the primary involvement. The isolates were identified as HIVs by antigenic cross-reactivity and nucleic acid hybridizations to HIV-specific antibodies and DNA probes. The replication and cytopathic properties of these isolates were studied and compared with lymphadenopathy-associated virus (HIVLAV). All isolates had replication competence equivalent to LAV, but four isolates did not kill T4 (CD-4) cells. This isolation of non-cytocidal natural variants of HIV raises the possibility that in some AIDS cases the neurological disorders might be due to HIV variants that are non-cytocidal to T4 cells. The results also indicate that virus replication and cytotoxicity are not always concordant functions in HIV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886714     DOI: 10.1016/s0140-6736(87)90826-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cells.

Authors:  J L'age-Stehr; M Niedrig; H R Gelderblom; J W Sim-Brandenburg; M Urban-Schriefer; E P Rieber; J G Haas; G Riethmüller; H W Ziegler-Heitbrock
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Heterogeneity of the ARV-2 strain and natural isolates of the human immunodeficiency virus.

Authors:  A F Etkin; M I Bukrinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Neurological features in AIDS patients: studies on cerebrospinal fluid.

Authors:  L Ortona; E Tamburrini; A Antinori; G Ventura
Journal:  Ital J Neurol Sci       Date:  1988-12

4.  Generation of hybrid human immunodeficiency virus by homologous recombination.

Authors:  A Srinivasan; D York; R Jannoun-Nasr; S Kalyanaraman; D Swan; J Benson; C Bohan; P A Luciw; S Schnoll; R A Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 5.  Neurological complications of human immunodeficiency virus infection.

Authors:  P G Kennedy
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

6.  Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1.

Authors:  V Robert; M Resnicoff; J C Chermann; C Devaux
Journal:  Mol Cell Biochem       Date:  1991-04-10       Impact factor: 3.396

Review 7.  Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis.

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Detection of human herpes virus 6 (HHV 6) in the skin of a patient with primary HHV 6 infection and erythroderma.

Authors:  Y Sumiyoshi; K Akashi; M Kikuchi
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay.

Authors:  B A Larder; B Chesebro; D D Richman
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.